The feasibility, safety, and efficacy of lower limb garment-integrated blood flow restriction training in healthy adults.


Journal

Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
ISSN: 1873-1600
Titre abrégé: Phys Ther Sport
Pays: England
ID NLM: 100940513

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 28 09 2022
revised: 06 01 2023
accepted: 07 01 2023
pubmed: 15 1 2023
medline: 3 3 2023
entrez: 14 1 2023
Statut: ppublish

Résumé

Explore the feasibility of lower-limb garment-integrated BFR-training. Observational study. Human performance laboratory. Healthy males with no experience of BFR-training. Feasibility was determined by a priori thresholds for recruitment, adherence, and data collection. Safety was determined by measuring BFR torniquet pressure and the incidence of side effects. Efficacy was determined by measuring body anthropometry and knee isokinetic dynamometry. Feasibility and safety outcomes were reported descriptively or as a proportion with 95% confidence intervals (95% CI), with mean change, 95% CIs, and effect sizes for efficacy outcomes. Twelve participants (mean age 24.8 years [6.5]) were successfully recruited; 11 completed the study. 134/136 sessions were completed (adherence = 98.5%) and 100% of data were collected. There was one event of excessive pain during exercise (0.7%, 95% CI 0.0%, 4.0%), two events of excessive pain post-exercise (1.5%, 95% CI 0.4%, 5.5%), and one event of persistent paraesthesia post-exercise (0.7%, 95% CI 0.0%, 4.0%). Mean maximal BFR torniquet pressure was <200 mmHg. We observed an increase in knee extension peak torque (mean change 12.4 Nm), but no notable changes in body anthropometry. Lower-limb garment-integrated BFR-training is feasible, has no signal of important harm, and could be used independently.

Identifiants

pubmed: 36640641
pii: S1466-853X(23)00006-8
doi: 10.1016/j.ptsp.2023.01.006
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-16

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr Warren J. Bradley is the chief technical officer of Hytro Ltd. All other authors have no competing interests to declare.

Auteurs

Bradley S Neal (BS)

School of Sport, Rehabilitation & Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, United Kingdom. Electronic address: b.neal@essex.ac.uk.

Chris J McManus (CJ)

School of Sport, Rehabilitation & Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, United Kingdom.

Warren J Bradley (WJ)

Hytro Ltd, 2 Park Court, Pyford Road, West Byfleet, Surrey, KT14 6SD, United Kingdom.

Sam F Leaney (SF)

School of Sport, Rehabilitation & Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, United Kingdom.

Kelly Murray (K)

School of Sport, Rehabilitation & Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, United Kingdom.

Nicholas C Clark (NC)

School of Sport, Rehabilitation & Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH